Medication treatment for eating disorders

References

• Agras, W.S., Dorian, B., Kirkley, B.G., Arnow, B. & Bachman, J. (1987). Imipramine in the treatment of bulimia:a double-blind control-led study. International Journal of Eating Disorders, 6, 29–38.
   Web of Science ®Google Scholar
• A gras, W. S., Rossiter, E. M., Arnow, B., Schneider, J.A., Telch, C.F., Raeburn, S.D., Bruce, B., Perl, M. & Koran, L. M . (1992). Pharmacologic and cognitive-behavioraltreatment for bulimia nervosa: a controlled comparison. American Journal of Psychiatry, 49, 82–87.
   Google Scholar
• Alger, S.A., Schwalberg, M.D., Bigaouette,J.M., Michalek, A.V. & Howard, L.J. (1991). Effect of a tricyclic antidepressant and opiate an-tagonist on binge-eating in normow eight bulimic and obese, binge-eating subjects. American Journal of Clinical Nutrition, 53, 865–871.
   Google Scholar
• American Psychiatric Association, (1994). Di-agnostic and Statistical Manual of Mental Disorders (4th Ed.). Washington, DC, Ameri-can Psychiatric Association.
   Google Scholar
• Barlow, J., Blouin, J., Blouin, A. & Perez, E. (1988). Treatment of bulimia with desipramine: A double-blind crossover study. Canadian Journal of Psychiatry, 330, 129–133.
   Google Scholar
• Barry, V.C. & Klawans, H.L. (1976). On the role of dopamine in the pathophysiology of ano-rexia nervosa. Journal of Neural Transmis-sion, 38, 107–122.
   PubMed Web of Science ®Google Scholar
• Biederman, J., Herzog, D.B., Rivinus, TM., Harper, G.P., Ferber, R.A., Rosenbaum, J.F., Harmatz, J.S., Tondorf, R., Orsulak, P.J. & Schildkraut, J.J. (1985). Amitriptyline in the treatment of anorexia nervosa:a double-blind,placebo-controlled study. Journal of Clinical Psychopharmacology, 5, 10–16.
   Google Scholar
• Blouin, A.G., Blouin, J.H., Perez, EL., Bushnik, T., Zuro, C. & Mulder, E. (1988). Treatment ofbulimia with fenfluramine and de s ipramine . Journal of Clinical Psychopharmacology, 8, 261–269.
   Google Scholar
• Brenot, F., Herve, P., Petitpretz, P., Parent, F., Duroux, P. & Simonneau, G. (1993). Primary pulmonary hypertension and fenfluramine use. British Heart Journal, 70, 537–541.
   PubMedGoogle Scholar
• Casper, R.C., Schlemmer, R.F.,Jr. & Javaid, J.I. (1987). A placebo-controlled crossover study of oral clonidine in acute anorexia nervosa. Psychiatry Research, 20, 249–260.
   Google Scholar
• Channon, S. & DeSilva, W.P. (1985). Psycho-logical correlates of weight gain in patients with anorexianervosa. Journal of Psychiatric Research, 19, 267–271.
   PubMed Web of Science ®Google Scholar
• Crisp, A.H. (1966). A treatment regime for ano-rexia nervosa. British Journal of Psychiatry, 112, 505–512.
   Web of Science ®Google Scholar
• Dally, P. & Sargant, W. (1960). A new treatment of anorexia nervosa. British MedicalJournal, 1, 1770–1773.
   PubMed Web of Science ®Google Scholar
• Dally, P. & Sargant, W. (1966). Treatment and outcome of anorexia nervosa. British Medical Journal, 2, 793–795.
   PubMed Web of Science ®Google Scholar
• De Zwaan, M.,Nutzinger, D.O. & Schoenbeck, G. (1992). Binge eating in overweight women. Comprehensive Psychiatry, 33, 256–261.
   Google Scholar
• Eckert,E.D ., Goldberg, S.C.,Halmi,K.A.,Casper, R.C. & Davis, J.M. (1981). Depression in anorexia nervosa. Psychological Medicine, 11, 1–8.
   PubMed Web of Science ®Google Scholar
• Fahy, TA., Eisler, I. & Russell, G.F.M. (1993). A placebo-controlled trial of d-fenfluramine in bulimia nervosa. British Journal of Psychia-try, 162, 597–603.
   Google Scholar
• Fichter, M. M., Leibl, K., Rief, W., Brunner, E., Schmidt-Auberger, S. & Engel, R. R. (1991). Fluoxetine versus placebo: a double-blind study with bulimic inpatients undergoing intensive psychotherapy. Pharmaco-psychiatrica, 24, 1–7.
   Google Scholar
• Fluoxetine Bulimia Nervosa Collaborative Study Group, (1992). Fluoxetine in the treatment of bulimia nervosa: a multicenter, placebo-con-trolled, double-blind trial. Archives of Gen-eral Psychiatry, 49, 139–147.
   PubMed Web of Science ®Google Scholar
• Goldberg, S.C., Halmi, K.A., Eckert,E.D., Casper, R.C. & Davis, J.M. (1979). Cyproheptadine in anorexia nervosa. British Journal of Psychia-try, 134, 67–70.
   Google Scholar
• Gross, H.A., Ebert, M.H., Faden, VB., Goldberg, S.C., Nee, L.e. & Kaye, W.H. (1981). A dou-ble-blind controlled trial of lithium carbonate in primary anorexia nervosa. Journal ofClini-cal Psychopharmacology, 1, 376–381.
   Google Scholar
• Halmi, K.A., Eckert, E. D., LaDu, T.J. & Cohen, J. (1986). Anorexia nervosa:treatment effi-cacy of cyproheptadine and amitriptyline. Archives of General Psychiatry, 43, 177–181.
   Google Scholar
• Herzog, D.B. (1984). Are anorexic and bulimic patients depressed? American Journal ofPsy-chiatry, 141, 1594–1597.
   Google Scholar
• Home, R.L., Ferguson, J.M., Pope, H.G., Hud-son, J.I., Lineberry, C.G., Ascher, J. & Cato, A. (1988). Treatment of bulimia with bupropion:amulticentercontrolledtrial. Jour-nal of Clinical Psychiatry, 49, 262–266.
   PubMed Web of Science ®Google Scholar
• Hudson, J.I., Pope, H.G.Jr., Jonas, J.M. & Yurgelun Todd, D. (1983). Phenomenologic relationship of eating disorders to major affec-tive disorder. Psychiatry Research, 9, 345–354.
   Google Scholar
• Hughes, P.L., Wells, L.A., Cunningham, C.J. & Ilstrup, D.M. (1986). Treating bulimia with desipramine :a double-blind, placebo-control-led study. Archives of General Psychiatry, 43, 182–186.
   PubMed Web of Science ®Google Scholar
• Jonas, J.M. & Gold, M.S. (1986). Nahrexone reverses bulimic symptoms. Lancet, 807.
   Google Scholar
• Kaplan, AS., Garfinkel, P.E., Darby, P.L. & Garner, D.M. (1983). Carbamazepine in the treatment of bulimia. American Journal of Psychiatry, 140, 1225–1226.
   Google Scholar
• Kaye, W.H., We ltzin, T.E., Hsu, L.K.G. & Bu lik, C.M. (1991). An open trial of fluoxetine in patients with anorexia nervosa. Journal of Clinical Psychiatry, 52, 464–471.
   PubMed Web of Science ®Google Scholar
• Kennedy, S.H.,Piran, N., Warsh,J.J., Prendergast, P., Mainprize, E., Whynot, C. & Garfinkel, P.E. (1988). A trial of isocarboxazid in the treatment of bulimia nervosa. Journal of Clinical Psychopharmacology, 8, 391–396.
   Google Scholar
• Kennedy, S.H., Goldbloom, D.S., Ralevski, E., Davis, C., D'Souza, J. & Lofchy, J. (1993). Is there a role for selective MAO-inhibitor therapy in bulimia nervosa? A placebo-con-trolled trial of brofaromine. Journal of Clini-cal Psychopharmacology, 13, 415–422..
   Google Scholar
• Krahn, D. & Mitchell, J. (1985). Use of L-tryptophan in treating bulimia. American Journal of Psychiatry 142, 1130.
   PubMed Web of Science ®Google Scholar
• Lacey, J.H. & Crisp, A.H. (1980). Hunger, food intake and weight:the impact of clomipramine on a refeeding anorexia nervosa population. Postgraduate Medical Journal, 56-Suppl 1, 79–85.
   Google Scholar
• Marcus, M.D., Wing, R.R., Ewing, L., Kern, E., Gooding, W. & McDermott, M. (1990). A double-blind, placebo-controlled trial of fluoxetine plus behavior modification in the treatment of obese binge eaters and non-binge eaters. American Journal of Psychiatry, 147, 876–881.
   PubMed Web of Science ®Google Scholar
• McCann, U., Hatzidimitriou, G., Ridenour, A., Fischer, C., Yuan, J., Kanz, J. & Ricaurte, G. (1994). Dexfenfluramine and serotonin neurotoxicity: Furtherprec linical evidence that clinical caution is indicated. Journal of Phar-macology and Experimental Therapeutics, 269, 792–798.
   PubMed Web of Science ®Google Scholar
• McCann, U.D. & Agras, W. S. (1990). Successful treatment of nonpurging bulimia nervosa with de sipramine : a double-blind, placebo-control-led study. American Journal of Psychiatry, 147, 1509–1513.
   PubMed Web of Science ®Google Scholar
• Mitchell, J.E., Christenson, G., Jennings, J., Huber, M., Thomas, B., Pomeroy, C. & Morley, J. (1989a). A placebo-controlled, double-blind crossover study of naltrexone hydrochloride in outpatients with normal weight bulimia. Journal of Clinical Psychopharmacology, 9, 94–97.
   PubMed Web of Science ®Google Scholar
• Mitchell,J.E.,Pyle,R.L.,Eckert,E.D.,Hatsukami, D., Pomeroy, C. & Zimmerman, R. (1989b). Response to alternative antidepressants in imipramine nonresponders with bulimia ner-vosa. Journal of Clinical Psychopharma-cology, 9, 291–293.
   Web of Science ®Google Scholar
• Mitchell,J.E.,Pyle,R.L.,Eckert,E.D.,Hatsukami, D., Pomeroy, C. & Zimmerman, R. (1990). A comparison study of antidepre s sants and struc-tured group psychotherapy in the treatment of bulimia nervosa. Archives of General Psy-chiatry, 47, 149–157.
   PubMed Web of Science ®Google Scholar
• Mitchell, J.E. & Groat, R. (1984). A placebo-controlled, double-blind trial of am itripty line in bulimia. JournalofClinicalPsychopharma-cology, 4, 186–193.
   PubMed Web of Science ®Google Scholar
• Pope, H.G.Jr., Hudson, J.I., Jonas, J.M. & Yurgelun-Todd, D. (1983). Bulimia treated with imipramine: a placebo-controlled, dou-ble-blind study. American Journal of Psy-chiatry, 140, 554–558.
   Google Scholar
• Pope, H.G.Jr., Keck, P.E.Jr., McElroy, S.L. & Hudson, J.I. (1989). A placebo-controlled study of trazodone in bulimia nervosa. Jour-nal of Clinical Psychopharmacology, 9, 254–259.
   Google Scholar
• Pope, H.G.Jr. & Hudson, J.I. (1982). Treatment of bulimia with antidepressants. Psychopharma-cology, 78, 176–179.
   Google Scholar
• Russell, G. (1979). Bulimia nervosa: an ominous variant of anorexia nervosa. Psychological Medicine,9, 429–448.
   PubMed Web of Science ®Google Scholar
• Russell, G.F.M., Checkley, S.A., Feldman, J. & Eisler, I. (1988). A controlled trial of d-fenfluramine in bulimia nervosa. Clinical Neuropharmacology,11, Suppl. 1,S146–S159.
   Google Scholar
• Sabine, E.J., Yonace, A., Farrington, A .J., Barratt, K.H. & Wakeling, A. (1983). Bulimia nervosa:a placebo controlled double-blind therapeutic trialofmianserin. British Journal of Clinical Pharmacology, 15, 195S–202S.
   Google Scholar
• Slaiman, S. (1989). Restricted diets restrict anti-depressant efficacy. The Practitioner, 233, 974–975.
   Google Scholar
• Vandereycken, W. (1984). Neuroleptics in the short-term treatment of anorexia nervosa:a double-blind placebo-controlled study with sulpiride. British Journal of Psychiatry, 144, 288–292.
   PubMed Web of Science ®Google Scholar
• Vandereycken, W. &Pierloot,R. (1982). Pimozide combined with behavior therapy in the short-term treatment of anorexia nervosa. Acta Psychiatrica Scandinavica, 66, 445–450.
   Google Scholar
• Vigersky, R.A. & Loriaux, D.L. (1977). The effect of cyproheptadine in anorexia nervosa: a double-blind trial. In: R.A. Vigersky (Ed.) Anorexia Nervosa. New York, Raven Press.
   Google Scholar
• Walsh, B.T.,Roose, S.P., Glassman, A .H., Gladis, M. & Sadik, C. (1985). Bulimia and depres-sion. Psychosomatic Medicine, 47, 123–131.
   PubMed Web of Science ®Google Scholar
• Walsh, B.T., Gladis, M., Roose, S.P., Stewart, J.W., Stetner, F. & Glassman, A.H. (1988). Phenelzine vs placebo in 50 patients with bulimia. Archives of General Psychiatry,45, 471–475.
   PubMed Web of Science ®Google Scholar
• Walsh, B .T., Hadigan, C. M., Devlin, M.J.,Gladis, M. & Roose, S.P. (1991). Long-term outcome of antidepressant treatment for bulimia ner-vosa. American Journal of Psychiatry, 148, 1206–1212.
   Google Scholar
• Weintraub, M. (1992). Long-term weight control: The National Heart, Lung, and Blood Institute funded multimodal intervention study. Clini-cal Pharmacology andTherapeutics, 51, 581–646.
   PubMed Web of Science ®Google Scholar
• Wermuth, B.M., Davis, K.L., Hollister, L.E. & Stunkard, A.J. (1977). Phenytoin treatment of the binge-eating syndrome. American Jour-nal of Psychiatry, 34, 1249–1253.
   Google Scholar